Medical Research

The development of new treatments and methods of diagnosis is vital to our understanding of chILD. Research but how helping chILD children live day to day with their disease.

Please check out our ‘Get Involved’ section on how you can help us raise funds to enable us to look for our answers.

ChILD UK has contributed to the following medical research:

Two awards were given for the funds raised from Team Bronchiolitis Obliterans

Role of microRNAs in the pathophysiology of bronchiolitis obliterates.

The grant provides $50,500 in funding to Martin Rosewich (MD), Germany

Epithelial-mesenchymal transition in pediatric airway epithelial cells following infection with bronchiolitis obliterans associated adenoviruses.

The grant provides $50,500 in funding to Stephen Stick (MB, BChir, PhD), Western Australia.

The survey was created and distributed around the chILD UK community early 2014. Due to the information the survey collected, it became of interest within the medical community who recommended the survey to be published. It was published at Pediatric Pulmonology in January 2015.

Please find a copy of the paper with kind permission from Wiley Online: ChILD – Family Perspectives

“Genetic Discovery in Familial Neuroendocrine Cell Hyperplasia of Infancy.”

Lisa R. Young, MD, Associate Professor of Pediatrics and Medicine at Vanderbilt University School of Medicine. The grant provides $50,000 in funding.

Neuroendocrine cell Hyperplasia of Infancy (NEHI) is a poorly understood disorder that most commonly causes fast breathing and low oxygen levels in young infants. The symptoms last for years, and there are currently no effective therapies. There are some families in which more than one individual has NEHI, suggesting that NEHI might be inherited in some cases. The strategies proposed in Dr. Young’s project evaluate the clinical manifestations of NEHI in families and will enable the most efficient approach for determining the genetic cause(s) of NEHI. Identifying the genetic cause of NEHI will enable less invasive diagnosis of NEHI and provide knowledge, which holds promise for developing future therapies for this disease.